160 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Attracts, retains, and incentivizes talented executives capable of leading our business in a highly complex and competitive environment 1 2 100
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “environmental laws
SC TO-T
EX-99
iwey9ju0i2q ww
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
tfw3m19q36033 y41p4
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
EX-1.1
506m 729jz2qyep3
13 Nov 23
Other Events
4:19pm
DEFA14A
t1i3o qfaneb6fgjb
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
2ig6xfl
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
f4h1tk mvc
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
nuwkaukbf49zxpjzln
17 Jun 22
Third party tender offer statement
4:42pm
8-K
EX-99.3
355fogqpfmbipu8f0sl
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.1
t2c32i ym
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
o9t c6wk63x4
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-1.1
8wc52idqwxu3p3az14
22 Feb 22
Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes
6:01am
8-K
EX-99.3
2i0o8dntf4o acp33dp
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
lnvxywmj93mnm83
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am